Compare Adaptive Biotechnologies Corp (ADPT) vs Intel Corp (INTC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Intel Corp — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Intel Corp trades at $109.9 (market cap $554.82B). The key difference: Intel Corp is far larger — about 166.6× Adaptive Biotechnologies Corp's market cap, and Intel Corp pays a 2.24% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | INTC | |
|---|---|---|
Market Cap | $3.33B | $554.82B |
Sector | Health | Technology |
52-Week High | $22.37 | $140.94 |
52-Week Low | $10.24 | $19.31 |
Enterprise Value | $3.19B | $567.06B |
Volume | — | 43,552,012 |
Dividend Yield | — | 2.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
